Mitochondrial Function and mtDNA Deletions in Sarcopenia
Mitochondrial Function and mtDNA Deletions in Sarcopenia
批准号:
6679301
负责人:
DEBRA L WATERS
金额:
$14.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-15 至 2005-06-30
关键词:
aging biopsy body physical activity clinical research dietary supplements gene deletion mutation human data human middle age (35-64) human old age (65+) human subject longitudinal human study magnetic resonance imaging method development mitochondria mitochondrial DNA muscle metabolism nutrient intake activity questionnaires sarcopenia striated muscles
中文摘要
描述(由申请人提供):有证据表明,由于氧化应激增加和/或抗氧化防御能力降低而导致的线粒体DNA(MtDNA)年龄相关缺失达到关键阈值,导致细胞损伤,最终导致肌肉质量和功能丧失。我们建议确定31P磁共振波谱(31P MRS)对体内线粒体功能的无创性测量是否与体外(活组织)线粒体功能和线粒体DNA缺失(MtDNA)测量相关,并探讨长期身体功能/体力活动与营养/补充剂摄入量之间的关系。我们假设,与年龄和性别匹配的非石棺生成老年人相比,更年长的石棺生成成年人身体更虚弱,表现出明显更多的线粒体功能障碍和mtDNA缺失的证据。这项建议将利用一种新的多学科方法,使用体内肌肉线粒体功能的测量(31P MRS)和体外线粒体功能的活组织检查(复合体I和IV活动以及mtDNA缺失),以更好地确定骨骼减少、线粒体功能和mtDNA缺失之间的关系。28名健康的非骨质疏松症和骨质疏松症老年受试者将在同一肌肉中进行动态31P MRS测试(线粒体功能)和骨骼肌活检,以确定线粒体功能(复合体I和IV活性)和mtDNA缺失。关于体力活动、身体机能、营养和维生素/补充剂摄入量的五到十年的现有纵向数据,将调查这些指标的关联关系。由于骨量减少与老年人的残疾增加有关,将这些发现转化为具有临床结果的新型干预措施的对照试验,将使我们能够开始揭示不同治疗方法可能导致更好地识别面临风险的老年人以及改进预防或逆转骨量减少的方法的精确机制。
英文摘要
DESCRIPTION (provided by applicant): There is evidence that age-related deletions in mitochondrial DNA (mtDNA) secondary to increased oxidative stress and/or decreased antioxidant defense reach a critical threshold, resulting in cellular damage and ultimately the loss of muscle mass and function. We propose to determine if the non-invasive in vivo measure of mitochondrial function by 31Phosphorus magnetic resonance spectroscopy (31P MRS), is correlated to in vitro (biopsy) measures of mitochondrial function and mitochondrial DNA deletions (mtDNA), and to investigate the relationships between long-term physical function/physical activity, and nutritional/supplement intake with these measures in sarcopenic and non-sarcopenic elderly. We hypothesize that older sarcopenic adults will be more frail physically and display significantly more evidence of mitochondrial dysfunction and mtDNA deletions compared to age-and sex-matched non- sarcopenic elderly. This proposal will utilize a novel, multi-disciplinary approach using an in vivo measure of muscle mitochondrial function (31P MRS), and in vitro biopsy measures of mitochondrial function (Complex I and IV activities and mtDNA deletions to better define relationships between sarcopenia, mitochondrial function, and mtDNA deletions. Twenty-eight healthy non-sarcopenic, and sarcopenic elderly subjects will have a dynamic 31P MRS test (mitochondrial function) and a skeletal muscle biopsy in the same muscle to determine mitochondrial function (Complex I and IV activities) and mtDNA deletions. Five -ten years of existing longitudinal data on physical activity, physical function, nutrition, and vitamin/supplement intake and these measures will be investigated for associated relationships. As sarcopenia is related to increasing disability in the elderly, the translation of these findings to controlled trials of novel interventions with clinical outcomes, will allow us to begin to uncover the precise mechanisms by which different therapies may lead to better identification of aging adults at risk, and improved approaches for the prevention or reversal of sarcopenia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Function and mtDNA Deletions in Sarcopenia
-
批准号:6937658
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2003
-
负责人:DEBRA L WATERS
-
依托单位:
HPA, GH/IGF-1& Leptin Alterations in Elderly Obese
-
批准号:7043215
-
项目类别:
-
资助金额:$16.59万
-
财政年份:2003
-
负责人:DEBRA L WATERS
-
依托单位:
海外基金